Elena Tsoy1, Rachel E Kiekhofer1, Elan L Guterman2, Boon Lead Tee1, Charles C Windon1, Karen A Dorsman3, Serggio C Lanata1,4, Gil D Rabinovici1,5,6, Bruce L Miller1,4, Amy J H Kind7,8, Katherine L Possin1,4. 1. Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco. 2. Department of Neurology, University of California, San Francisco, San Francisco. 3. Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas. 4. Global Brain Health Institute, University of California, San Francisco, San Francisco. 5. Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco. 6. Associate Editor, JAMA Neurology. 7. Division of Geriatrics, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison. 8. Geriatrics Research Education and Clinical Center, Madison Veterans Affairs Hospital, Madison, Wisconsin.
Abstract
Importance: The US aging population is rapidly becoming more racially and ethnically diverse. Early diagnosis of dementia is a health care priority. Objective: To examine the associations between race/ethnicity and timeliness of dementia diagnosis and comprehensiveness of diagnostic evaluation. Design, Setting, and Participants: This retrospective cross-sectional study used 2013-2015 California Medicare fee-for-service data to examine the associations of race/ethnicity, individual factors, and contextual factors with the timeliness and comprehensiveness of dementia diagnosis. Data from 10 472 unique beneficiaries were analyzed. The sample was selected on the basis of the following criteria: presence of 1 or more claims; no diagnoses of dementia or mild cognitive impairment in 2013 to 2014; continuous enrollment in Medicare Parts A and B; Asian, Black, Hispanic, or White race/ethnicity; and incident diagnoses of dementia or mild cognitive impairment in January through June 2015. Data analyses were conducted from November 1, 2019, through November 10, 2020. Main Outcomes and Measures: Timeliness of diagnosis, defined as incident diagnosis of mild cognitive impairment vs dementia, and comprehensiveness of diagnostic evaluation, defined as presence of the following services in claims within 6 months before or after the incident diagnosis date: specialist evaluation, laboratory testing, and neuroimaging studies. Results: The sample comprised 10 472 unique Medicare beneficiaries with incident diagnoses of dementia or mild cognitive impairment (6504 women [62.1%]; mean [SD] age, 82.9 [8.0] years) and included 993 individuals who identified as Asian (9.5%), 407 as Black (3.9%), 1255 as Hispanic (12.0%), and 7817 as White (74.6%). Compared with White beneficiaries, those who identified as Asian (odds ratio, 0.46; 95% CI, 0.38-0.56), Black (odds ratio, 0.73; 95% CI, 0.56-0.94), or Hispanic (odds ratio, 0.62; 95% CI, 0.52-0.72) were less likely to receive a timely diagnosis. Asian beneficiaries (incidence rate ratio, 0.81; 95% CI, 0.74-0.87) also received fewer diagnostic evaluation elements. These associations remained significant after adjusting for age, sex, comorbidity burden, neighborhood disadvantage, and rurality. Conclusions and Relevance: These findings highlight substantial disparities in the timeliness and comprehensiveness of dementia diagnosis. Public health interventions are needed to achieve equitable care for people living with dementia across all racial/ethnic groups.
Importance: The US aging population is rapidly becoming more racially and ethnically diverse. Early diagnosis of dementia is a health care priority. Objective: To examine the associations between race/ethnicity and timeliness of dementia diagnosis and comprehensiveness of diagnostic evaluation. Design, Setting, and Participants: This retrospective cross-sectional study used 2013-2015 California Medicare fee-for-service data to examine the associations of race/ethnicity, individual factors, and contextual factors with the timeliness and comprehensiveness of dementia diagnosis. Data from 10 472 unique beneficiaries were analyzed. The sample was selected on the basis of the following criteria: presence of 1 or more claims; no diagnoses of dementia or mild cognitive impairment in 2013 to 2014; continuous enrollment in Medicare Parts A and B; Asian, Black, Hispanic, or White race/ethnicity; and incident diagnoses of dementia or mild cognitive impairment in January through June 2015. Data analyses were conducted from November 1, 2019, through November 10, 2020. Main Outcomes and Measures: Timeliness of diagnosis, defined as incident diagnosis of mild cognitive impairment vs dementia, and comprehensiveness of diagnostic evaluation, defined as presence of the following services in claims within 6 months before or after the incident diagnosis date: specialist evaluation, laboratory testing, and neuroimaging studies. Results: The sample comprised 10 472 unique Medicare beneficiaries with incident diagnoses of dementia or mild cognitive impairment (6504 women [62.1%]; mean [SD] age, 82.9 [8.0] years) and included 993 individuals who identified as Asian (9.5%), 407 as Black (3.9%), 1255 as Hispanic (12.0%), and 7817 as White (74.6%). Compared with White beneficiaries, those who identified as Asian (odds ratio, 0.46; 95% CI, 0.38-0.56), Black (odds ratio, 0.73; 95% CI, 0.56-0.94), or Hispanic (odds ratio, 0.62; 95% CI, 0.52-0.72) were less likely to receive a timely diagnosis. Asian beneficiaries (incidence rate ratio, 0.81; 95% CI, 0.74-0.87) also received fewer diagnostic evaluation elements. These associations remained significant after adjusting for age, sex, comorbidity burden, neighborhood disadvantage, and rurality. Conclusions and Relevance: These findings highlight substantial disparities in the timeliness and comprehensiveness of dementia diagnosis. Public health interventions are needed to achieve equitable care for people living with dementia across all racial/ethnic groups.
Authors: Ganesh M Babulal; Yiqi Zhu; Catherine M Roe; Darrell L Hudson; Monique M Williams; Samantha A Murphy; Jason Doherty; Ann M Johnson; Jean-Francois Trani Journal: Alzheimers Dement Date: 2022-02-25 Impact factor: 16.655
Authors: Huong Q Nguyen; Soo Borson; Peter Khang; Annette Langer-Gould; Susan E Wang; Jarrod Carrol; Janet S Lee Journal: Alzheimers Dement (N Y) Date: 2022-03-13
Authors: Jetske van der Schaar; Leonie N C Visser; Femke H Bouwman; Johannes C F Ket; Philip Scheltens; Annelien L Bredenoord; Wiesje M van der Flier Journal: Alzheimers Res Ther Date: 2022-02-10 Impact factor: 6.982
Authors: Rema Raman; Yakeel T Quiroz; Oliver Langford; Jiyoon Choi; Marina Ritchie; Morgan Baumgartner; Dorene Rentz; Neelum T Aggarwal; Paul Aisen; Reisa Sperling; Joshua D Grill Journal: JAMA Netw Open Date: 2021-07-01
Authors: Jing Li; Jorge J Llibre-Guerra; Amal Harrati; Jordan Weiss; Ivonne Z Jiménez-Velázquez; Daisy Acosta; Juan de Jesús Llibre-Rodriguez; Mao-Mei Liu; William H Dow Journal: Alzheimers Dement (N Y) Date: 2021-09-05